Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans

Serum irisin levels in new-onset type 2 diabetes

(2013) Yeon-Kyung Choi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle

(2013) Tizhong Shan et al.   FASEB JOURNAL

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass

(2013) Andrew G. Swick et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats

(2013) Michael D. Roberts et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Irisin: A renaissance in metabolism?

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs

(2013) John N. Fain et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines

(2013) Hyun-Seuk Moon et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine

(2013) Arturo Roca-Rivada et al.   PLoS One

Myostatin: more than just a regulator of muscle mass

(2012) Josep M. Argilés et al.   DRUG DISCOVERY TODAY

The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ

(2012) Steven S. Welc et al.   EXPERIMENTAL PHYSIOLOGY

Activins in adipogenesis and obesity

(2012) C Dani   INTERNATIONAL JOURNAL OF OBESITY

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

(2012) Joo Young Huh et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

Muscles, exercise and obesity: skeletal muscle as a secretory organ

(2012) Bente K. Pedersen et al.   Nature Reviews Endocrinology

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index

(2012) Andreas Stengel et al.   PEPTIDES

Irisin, Light My Fire

(2012) D. P. Kelly   SCIENCE

Irisin: A new potential hormonal target for the treatment of obesity and type 2 diabetes

(2012) Fabian Sanchis-Gomar et al.   Journal of Diabetes

Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis

(2011) Masashi Nakatani et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women

(2011) Mary Brinkoetter et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Energy Deprivation Alters in a Leptin- and Cortisol-Independent Manner Circulating Levels of Activin A and Follistatin But Not Myostatin in Healthy Males

(2011) Maria T. Vamvini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exercise Induces a Marked Increase in Plasma Follistatin: Evidence That Follistatin Is a Contraction-Induced Hepatokine

(2010) Jakob Hansen et al.   ENDOCRINOLOGY

Myostatin Decreases with Aerobic Exercise and Associates with Insulin Resistance

(2010) DUSTIN S. HITTEL et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study

(2010) Ole-Petter R. Hamnvik et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Regulation of Muscle Mass by Follistatin and Activins

(2010) Se-Jin Lee et al.   MOLECULAR ENDOCRINOLOGY